Using Electrocochleography During Cochlear Implantation of the Neuro Zti.

Cochlear Hearing Loss Clinical Trial

— PIC-22_eCoN  

Official title:

Using Electrocochleography to Guide Insertion of the Electrode Array During Cochlear Implantation of the Neuro Zti (eCoN)

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04651660
• Other study ID #: PIC-22
• Status: Withdrawn
• Phase: N/A
• Start date: January 2023
• Est. completion date: January 2024

Study information

• Verified date: March 2023
• Source: Oticon Medical
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The main objective of this study is to evaluate the correspondence between eCochG and residual hearing by adding two modifications. First, a novel technique for placing and maintaining the probe in place during the whole insertion will be used. Second, a new metric for estimating the eCochG response will be evaluated (eCochG trauma index). The secondary objective is to find other markers of the cochlear trauma insertion associated to eCochG measures. This will be used to evaluate to which extend a traumatic insertion will be deleterious for the patient's post-operative hearing, and ultimately to prevent trauma to the inner ear. Finally, the potential differences in cochlear trauma resulting of the electrode array insertion from two different surgery techniques will be investigated; Either using a manual insertion or using a robotic arm that will drive the insertion automatically.

Description:

Main study procedures and assessments:

• Visit 1 (D-30+/-14) INCLUSION: subject information/consent, inclusion/exclusion criteria, CT-scan, Tonal audiometry

• Visit 2 (D0+/-14) COCHLEAR IMPLANT SURGERY: CT-scan, Intra-op eCochG, eCAP, Impedance

• Visit 3 (D+30+/-14) FOLLOW-UP 1 MONTH: Tonal audiometry, Impedance, Fitting maps

• Visit 4 (D+60+/-14) FOLLOW-UP 2 MONTH: Tonal audiometry, Impedance, Fitting maps, Phonemes

• Visit 5 (D+90+/-14) FOLLOW-UP 3 MONTH: Tonal audiometry, Impedance, Fitting maps, Phonemes

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: January 2024
• Est. primary completion date: January 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• > or equal 18 years ;

• Candidate for Neuro Zti EVO cochlear implant system, unilateral or bilateral recipient ;

• Preoperative residual hearing with audiometric thresholds less or equal than 80 dB at 500 Hz, or higher frequencies

Exclusion Criteria:

• Medical or psychological conditions which contraindicate surgery (e.g middle ear infection, tympanic membrane perforation) ;

• Patient with a psychological or linguistic inability to understand the information sheet ;

• Patient under legal protection or deprived of liberty

• Patient included and participating to another trial.

Related Conditions & MeSH terms

• Cochlear Hearing Loss
• Cochlear Trauma
• Hearing Loss
• Hearing Loss, Sensorineural

Intervention

Device:
• Neuro Cochlear Implant System
Before the mastoidectomy, the ear canal is cleaned, the insert earphone is connected to the Eclipse (Oticon Medical software) preamplifier and placed into the ear canal. The EEG scalp electrodes (active, ground electrode) are placed on the patient's head. After the posterior tympanotomy, the reference electrode (eCochG probe) is placed on the cochlear promontory. The CI electrode array will be inserted following one of the two possible techniques while the eCochG will be recording. The surgeon will either manually insert the array using the Oticon Medical stylet and following the surgery guides and recommendations from Oticon Medical or will control the Robotol insertion angle and drive the robotic arm in the same way.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Oticon Medical

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Correlation coefficient between the eCochG trauma index (in µV) and the residual hearing (in dB HL).	The eCochG trauma index correspond to electrophysiological changes of the cochlear response during the CI electrode insertion, and is calculated from the difference between post-insertion and pre-insertion eCochG measure (in µV).; The hearing loss is calculated from the difference between the post-surgical and pre-surgical hearing thresholds (in dB HL).; The correspondence is calculated from the correlation coefficient between the eCochG trauma index and the hearing loss.; It is expected that a potential damage measured by the eCochG during the surgery have affected auditory threshold.	Through study completion, an average of 2 years
Secondary	Significant decrease of eCochG trauma index (in µV) for electrode array insertion performed manually compared to robotic.	eCochG trauma index (µV) as a result of manual electrode insertion compared with robotic insertion.; Different behaviors of audiological markers since the cochlea may have suffered from biological cell degradation due to the CI electrode insertion. Allied with cochlear degradation will come increased tissue scar density, subsequently increased resistivity of the biological field to the electrical current. This would imply a cascade effect of electrical and audiological outcomes (higher impedances, higher electrical charges required to evoke a sound or the auditory nerve feedback - eCAP, lower overall performances).	Through study completion, average of 2 years
Secondary	Correlation coefficient between the eCochG trauma index (in µV) and a misplacement of the electrode array inside the cochlea based on CT scan.	The misplacement will be quantified with the cochlear coverage (in %) and a subjective assessment of the Eschraghi trauma index for exploratory purpose.; eCochG trauma index (µV) with placement of the CI electrode array in the cochlea (using Pre and Post surgical CT scans).	Through study completion, average of 2 years
Secondary	Correlation coefficient between the eCochG trauma index (in nV) with the electrical charges (in nC) required to elicit eCAP threshold.	eCochG trauma index (µV) with eCAP thresholds (nC).	Through study completion, average of 2 years
Secondary	Correlation coefficient between the eCochG trauma index (in nV) with impedance measurement (in ?).	eCochG trauma index (µV) with CI electrode impedances (Ohm).	Through study completion, average of 2 years
Secondary	Correlation coefficient between the eCochG trauma index (in nV) with fitting map electrical charges (in nC), and slopes of their growth functions.	eCochG trauma index (µV) with electrical charge (nC) measured on the patient CI fitting map.	Through study completion, average of 2 years
Secondary	Correlation coefficient between the eCochG trauma index (in nV) with scores of phonemes discrimination (%).	eCochG trauma index (µV) with scores (in %) of phonemes recognition.	Through study completion, average of 2 years